IVF
3
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program1
Combination therapy : Follitropin delta and HP-hMGPhase 21 trial
Active Trials
GuerbetFrance - Villepinte
1 programLipiodol® uterine treatment prior to IVF/ICSIN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Ferring PharmaceuticalsCombination therapy : Follitropin delta and HP-hMG
Gedeon RichterLetrozole 5 mg
One Biosciences17-beta estradiol
GuerbetLipiodol® uterine treatment prior to IVF/ICSI
Clinical Trials (4)
Total enrollment: 1,009 patients across 4 trials
Menopur And Rekovelle Combination Study Version 2.0
Start: Jul 2025Est. completion: Aug 2027200 patients
Phase 2Recruiting
RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2
Start: Sep 2018Est. completion: Nov 202025 patients
Phase 2Completed
Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles
Start: May 2016Est. completion: Jun 2018
Phase 2Unknown
Lipiodol Prior to FET (LIFE)
Start: Aug 2024Est. completion: Dec 2026784 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,009 patients
4 companies competing in this space